Castle Biosciences to share portfolio of GEP tests at FC23

Castle Biosciences announced that it will share new data across its dermatologic portfolio of gene expression profile, GEP, tests at the 2023 Fall Clinical Dermatology Conference, FC23, taking place Oct. 19-22, 2023, in Las Vegas. “The breadth of data we are sharing at Fall Clinical reinforces our commitment to improving the care of patients with skin cancers and inflammatory skin conditions through innovative tests that can guide more informed disease management decisions,” said Derek Maetzold, president and chief executive officer of Castle Biosciences.